Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. VANI
stocks logo

VANI

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
--
--
-0.090
-18.18%
--
--
-0.090
-18.18%
--
--
-0.090
-25%
Estimates Revision
The market is revising No Change the revenue expectations for Vivani Medical, Inc. (VANI) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 9.30%.
EPS Estimates for FY2025
Revise Downward
down Image
-5.75%
In Past 3 Month
Stock Price
Go Up
up Image
+9.30%
In Past 3 Month
Wall Street analysts forecast VANI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VANI is 4.00 USD with a low forecast of 4.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast VANI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VANI is 4.00 USD with a low forecast of 4.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.410
sliders
Low
4.00
Averages
4.00
High
4.00
Current: 1.410
sliders
Low
4.00
Averages
4.00
High
4.00
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$4
2025-04-16
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$4
2025-04-16
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$4
2025-04-04
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$4
2025-04-04
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$4
2025-03-26
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$4
2025-03-26
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$4
2025-03-13
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$4
2025-03-13
Reiterates
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Vivani Medical Inc (VANI.O) is -4.03, compared to its 5-year average forward P/E of -2.52. For a more detailed relative valuation and DCF analysis to assess Vivani Medical Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-2.52
Current PE
-4.03
Overvalued PE
-1.36
Undervalued PE
-3.68

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.93
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
1.18
Undervalued EV/EBITDA
-3.04

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

VANI News & Events

Events Timeline

(ET)
2025-11-13
07:47:20
Vivani Medical announces Q3 earnings per share of (11c), unchanged from last year.
select
2025-10-03 (ET)
2025-10-03
08:32:14
Vivani Medical cancels record date for Cortigent spin-off
select
2025-09-17 (ET)
2025-09-17
08:39:00
Vivani Medical reveals plans to spin off its Cortigent subsidiary
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
11-13Newsfilter
Vivani Medical Shares Business Update and Announces Financial Results for Third Quarter 2025

  • Clinical Development Plans: Vivani Medical plans to initiate a Phase 1 clinical study of its semaglutide implant for chronic weight management in the first half of 2026, with parallel investments for a Phase 2 study pending regulatory feedback.

  • Financial Position: The company raised approximately $25.7 million through private placements and financings in 3Q 2025 to support the accelerated development of its NPM-139 implant, ensuring financial stability into 2027.

  • Recent Achievements: Vivani successfully completed the LIBERATE-1 clinical study, marking a significant milestone for its NanoPortal™ technology, which aims to improve medication adherence and tolerability for obesity treatment.

  • Spin-off Update: The planned spin-off of Vivani's subsidiary, Cortigent, has been temporarily withdrawn due to the U.S. federal government shutdown, with a new record date expected to be established once normal SEC operations resume.

[object Object]
Preview
8.5
10-29NASDAQ.COM
GNTA, BBIO, AMRN Surge in After-Hours Trading: Major Biotech Factors Fueling Stock Increases

  • Genenta Science S.p.A. Update: After a significant drop in regular trading due to a $15 million capital raise announcement, Genenta's shares saw a modest recovery in after-hours trading, indicating potential stabilization as investors assess the long-term impact of the company's strategic collaborations.

  • EDAP TMS S.A. Recovery: Despite a sharp decline during the day, EDAP's stock rebounded in after-hours trading, reflecting renewed speculative interest, particularly ahead of upcoming investor meetings at the UBS Global Healthcare Conference.

  • BridgeBio Pharma Inc. Anticipation: BridgeBio's shares rose significantly after hours, driven by investor optimism regarding the upcoming Phase 3 trial results for ADH1, with topline data expected to be released soon.

  • OrthoPediatrics Corp. Financial Performance: Following the release of its Q3 financial results, OrthoPediatrics experienced a surge in after-hours trading, buoyed by revenue growth and FDA approvals, leading to an optimistic revision of its full-year revenue guidance.

[object Object]
Preview
8.5
10-27SeekingAlpha
Vivani Medical sets share price at $1.62 for $16M offering

  • Offering Details: Vivani Medical has priced a registered direct offering of 6 million shares at $1.62 each, along with a concurrent private placement of approximately 3.7 million shares at the same price, purchased by the company's chairman, Gregg Williams.

  • Financial Impact: The total gross proceeds from both offerings are expected to be around $15.7 million, which will be used for ongoing research, clinical development, and general corporate purposes.

  • Closing Date: The registered offering and private placement are anticipated to close on or about October 28, 2025.

  • Market Compliance: Both offerings were priced "at-the-market" in accordance with Nasdaq regulations.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Vivani Medical Inc (VANI) stock price today?

The current price of VANI is 1.41 USD — it has increased 0.71 % in the last trading day.

arrow icon

What is Vivani Medical Inc (VANI)'s business?

Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.

arrow icon

What is the price predicton of VANI Stock?

Wall Street analysts forecast VANI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VANI is 4.00 USD with a low forecast of 4.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Vivani Medical Inc (VANI)'s revenue for the last quarter?

Vivani Medical Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

arrow icon

What is Vivani Medical Inc (VANI)'s earnings per share (EPS) for the last quarter?

Vivani Medical Inc. EPS for the last quarter amounts to -0.11 USD, decreased -0.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Vivani Medical Inc (VANI)'s fundamentals?

The market is revising No Change the revenue expectations for Vivani Medical, Inc. (VANI) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 9.30%.
arrow icon

How many employees does Vivani Medical Inc (VANI). have?

Vivani Medical Inc (VANI) has 42 emplpoyees as of December 05 2025.

arrow icon

What is Vivani Medical Inc (VANI) market cap?

Today VANI has the market capitalization of 103.23M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free